CARSTEN BOESS Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for CARSTEN BOESS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of CARSTEN BOESS. CARSTEN BOESS is SVP, Chief Financial Officer in SYNAGEVA BIOPHARMA CORP ($GEVA).

CARSTEN BOESS in SYNAGEVA BIOPHARMA CORP

Trading Symbol: GEVA
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CARSTEN BOESS: SVP, Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Feb 19 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of CARSTEN BOESS in SYNAGEVA BIOPHARMA CORP

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM40.7429,0621,183,98615,938
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.7013,23522,5009,929
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS101.691,842187,31301.8 K to 0 (-100.00 %)
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS100.7416,7161,683,9701,84218.6 K to 1.8 K (-90.07 %)
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS99.9714,7501,474,55818,55833.3 K to 18.6 K (-44.28 %)
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS98.858,989888,56333,30842.3 K to 33.3 K (-21.25 %)
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM40.7429,0621,183,98642,29713.2 K to 42.3 K (+219.58 %)
Feb 19 2015GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.7013,23522,50013,2350 to 13.2 K
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM23.007,854180,6427,292
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.7015,05025,58523,164
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM23.001,00023,00015,146
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.701,5002,55038,214
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS80.1122,9041,834,839022.9 K to 0 (-100.00 %)
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM23.007,854180,64222,90415.1 K to 22.9 K (+52.19 %)
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.7015,05025,58515,0500 to 15.1 K
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS80.001,00080,00001,000 to 0 (-100.00 %)
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS80.001,500120,0001,0002.5 K to 1,000 (-60.00 %)
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM23.001,00023,0002,5001.5 K to 2.5 K (+66.67 %)
Oct 30 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.701,5002,5501,5000 to 1.5 K
Jun 05 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseA80.3540,0003,214,00040,000
May 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.709,92716,87639,714
May 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS83.4620016,6920200 to 0 (-100.00 %)
May 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS82.711,591131,5922001.8 K to 200 (-88.83 %)
May 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS81.758,136665,1181,7919.9 K to 1.8 K (-81.96 %)
May 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.709,92716,8769,9270 to 9.9 K
Feb 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.709,92716,87649,641
Feb 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS104.2289493,1730894 to 0 (-100.00 %)
Feb 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS103.051,745179,8228942.6 K to 894 (-66.12 %)
Feb 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS102.183,207327,6912,6395.8 K to 2.6 K (-54.86 %)
Feb 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS101.143,081311,6125,8468.9 K to 5.8 K (-34.51 %)
Feb 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS100.071,000100,0708,9279.9 K to 8.9 K (-10.07 %)
Feb 20 2014GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.709,92716,8769,9270 to 9.9 K
Nov 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.709,92716,87659,568
Nov 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS57.2050028,6000500 to 0 (-100.00 %)
Nov 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS55.993,801212,8185004.3 K to 500 (-88.37 %)
Nov 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS54.971,76597,0224,3016.1 K to 4.3 K (-29.10 %)
Nov 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS53.983,861208,4176,0669.9 K to 6.1 K (-38.89 %)
Nov 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.709,92716,8769,9270 to 9.9 K
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM23.006,681153,66316,146
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM23.002,17349,97922,827
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.705,6279,56669,495
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS47.196,681315,27606.7 K to 0 (-100.00 %)
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM23.006,681153,6636,6810 to 6.7 K
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS47.047,800366,91207.8 K to 0 (-100.00 %)
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM23.002,17349,9797,8005.6 K to 7.8 K (+38.62 %)
Aug 22 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.705,6279,5665,6270 to 5.6 K
Aug 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.704,3007,31075,122
Aug 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS47.474,300204,12104.3 K to 0 (-100.00 %)
Aug 20 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.704,3007,3104,3000 to 4.3 K
Jul 15 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseM1.7013,23722,50379,422
Jul 15 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...SellS47.0613,237622,933013.2 K to 0 (-100.00 %)
Jul 15 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...BuyM1.7013,23722,50313,2370 to 13.2 K
Jun 10 2013GEVASYNAGEVA BIOPHARMA ...BOESS CARSTENSVP, Chief Financia ...Option ExerciseA40.3245,0001,814,40045,000

Page:   1

Contact us | Follow us on Twitter